Skip to content

Clinical trials

Completed Phase 3 Retinopathy of Prematurity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinopathy of Prematurity Phase: Phase 3 Status: Completed Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20081
20131
20151
20161
20192
20203
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
Novartis Pharmaceuticals2
Alexandria University1
Cairo University1
Carola Pfeiffer-Mosesson1
McMaster University1
NICHD Neonatal Research Network1
Nabeel Ali1
National Eye Institute (NEI)1
Regeneron Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinopathy of Prematurity13
Premature Birth3
Bronchopulmonary Dysplasia2
Anemia1
Hydrocephalus1
Infant, Newborn, Diseases1
Leukomalacia, Periventricular1
Pain1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.